Stryker (NYSE:SYK) announced today that it launched the Insignia hip stem for total hip and hemiarthroplasty procedures.
Presenting at the American Academy of Orthopaedic Surgeons (AAOS) 2022 Annual Meeting in Chicago, Stryker introduced the Insignia hip stem for optimizing patient fit and surgeon ease of implantation in muscle-sparing approaches for total hip and hemiarthroplasty procedures.
Insignia has compatibility with Stryker’s Mako SmartRobotics platform utilizing Total Hip 4.1 software, allowing surgeons to use data from a 3D, CT-based plan to capture each patient’s unique anatomy, according to a news release.
The platform includes Tri-Stage broach featuring three different tooth geometries, along with unique, size-specific collar lengths and a range of femoral offsets for enhanced fit and function. Insignia also has a low-profile soldier, short stem lengths and distal relief to ease lateralization and insertion during muscle-sparing approaches such as direct anterior.
Stryker said Insignia adds to its advanced digital healthcare offerings, including extending the capabilities of the Mako robot-assisted surgical platform
“We’re excited to now offer surgeons a collared, fully HA-coated hip stem designed for muscle-sparing approaches like direct anterior,” Stryker VP and GM for Hips Katherine Truppi said in the release. “Insignia joins Stryker’s family of market-leading hip stems to complement our primary hip portfolio. Compatible with Mako SmartRobotics, Insignia delivers patient-specific fit, function and flexibility, allowing surgeons to further enhance patient outcomes.”
